Hexiris Inc.
$75,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- November 7, 2022 – February 29, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q3-997106
Published purpose
Presenting early-stage glaucoma patients with a minimally invasive approach to lower intraocular pressure with a bleb-forming procedure as an alternative to traditional trabeculectomy or tube surgery. Minimally Invasive Bleb-Forming Punch (MIBP) uses a new, creative injector punch to drain the liquid out of the eye. The punch removes tissue creating a tunnel to allow the eye to drain without the need for an implant. This next generation glaucoma surgery is targeted to early-stage patients as an outpatient procedure. Although the MIBS devices depend on creating an external filtering bleb, they are associated with fewer risks than traditional glaucoma surgeries, offering a favorable safety profile procedure with faster recovery.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.